To determine whether the CD109 protein identified in the CSC procedure of BxPC-3 cells was 1) expressed in pancreatic tumors and 2) upregulated in tumors compared with normal pancreas, IHC was performed on a panel of 18 tissues sections with PDAC and 11 sections with normal pancreas tissue. Here, CD109 is linked to pancreatic neoplasm.